Five women in Rajasthan seeking help after alleged postpartum kidney failure have drawn attention to postpartum acute kidney ...
Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...
Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ...
Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment ...
Dimerix has bought an acute kidney injury (AKI) drug from Mission Therapeutics, paying (PDF) $5 million upfront and ...
Five women from Rajasthan's Kota suffering from postpartum kidney failure have refused to continue dialysis and intensified ...
Postpartum kidney failure is a rare, life-threatening complication after childbirth that may require dialysis or transplantation if kidney function does not recover.
Mission Therapeutics of the UK has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, ...
Morning Overview on MSN
A common blood-pressure pill mixed with a routine antibiotic can trigger kidney injury
Patients who take a calcium-channel blocker for high blood pressure and then receive a prescription for clarithromycin, one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results